MEITAL STUDIOS INC – Trademark Portfolio
Entity Type: 03
MEITAL STUDIOS INC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include MONAD, EIKONÉO, LEIOCLÉS, ĀETHERAL, and SERAPHEEM. The owner is based in NORTH YORK, ON.
4401 BATHURST ST UNIT #300
NORTH YORK, ON M3H 3R9
Showing of trademarks Trademarks
Trademark Classifications
MEITAL STUDIOS INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does MEITAL STUDIOS INC have?
MEITAL STUDIOS INC has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does MEITAL STUDIOS INC file in?
MEITAL STUDIOS INC files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are MEITAL STUDIOS INC's most well-known trademarks?
MEITAL STUDIOS INC's registered trademark portfolio includes well-known marks such as MONAD, EIKONÉO, LEIOCLÉS, ĀETHERAL, and SERAPHEEM. These are among 7 currently registered trademarks in the portfolio.
What is MEITAL STUDIOS INC's trademark registration success rate?
MEITAL STUDIOS INC has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.